Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic AED recall: Medtronic/Physio-Control is recalling certain Lifepak CR Plus automated external defibrillators that, in extremely humid environments, may improperly analyze a patient's heart rhythm and delay or fail to deliver therapy to patients in cardiac arrest. The Medtronic subsidiary began calling customers on Aug. 18 and sending replacement devices on Aug. 19. FDA classified the recall as Class I, the most serious category, on Sept. 16. Several Lifepak CR Plus devices were recalled in Aug. 2008 because of a software glitch (1"The Gray Sheet" Sept. 15, 2008)
You may also be interested in...
Unexpected Clinical Trial Events: FDA Clarifies Sponsors’ Obligations To IRBs
FDA guidelines issued Jan. 15 put the onus on device and drug trial sponsors to identify which adverse events that arise during clinical studies need to be reported to institutional review boards
Physio-Control Class I Recall Unrelated To Broader Quality Issues, Firm Says
Physio-Control's Class I recall of 249 LifePak CR Plus automated external defibrillators, initiated Aug. 28, will not derail efforts to resolve long-standing quality deficiencies under an April FDA consent decree, the company says
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.